Aug. 10, 2005 — The U.S. Food and Drug Administration (FDA) approved in May revisions to safety labeling to advise that prophylactic use of fondaparinux sodium injection is associated with an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results